MyStocks

MEMBER'S LOGINX

Remember Username
Keep me signed in

(Please do not use this option on a public machine)

Print
Text -Size
RSS
FaceBook
Twitter
Linked In
WhatsApp

Home
Todays Market
Indian Stock Market Updates June 21, 2019

ALEMBIC PHARMA Surges by 6%; BSE HEALTHCARE Index Down 0.6%
Fri, 21 Jun 09:24 AM

ALEMBIC PHARMA share price has zoomed 6% and is presently trading at Rs 488.

Meanwhile, the BSE HEALTHCARE Index is at 12,797 (down 0.6%).

Among the top Gainers in the BSE HEALTHCARE Index today is ALEMBIC PHARMA (up 5.8%).

FORTIS HEALTHCARE (down 0.1%) and GLENMARK PHARMA (down 0.2%) are among the top losers today.

Over the last one year, ALEMBIC PHARMA has moved down from Rs 516 to Rs 488, registering a loss of Rs 28 (down 5.5%).

On the other hand, the BSE HEALTHCARE has moved down from 14,272 to 12,797, loss of 1,475 points (down 10.9%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were MERCK (up 52.4%), DIVIS LABORATORIES (up 46.1%) and J.B.CHEMICALS (up 40.4%).

DISCOVER: How to Potentially Multiply Your Returns by Upto 5x...

What About the Benchmark Indices?

The BSE Sensex is at 39,618 (down 0.5%).

The top gainers among the BSE Sensex stocks today are HCL TECHNOLOGIES (up 0.5%), ONGC (up 0.3%) and NTPC (up 0.3%). Other gainers include HUL (up 0.1%) and COAL INDIA . The most traded stocks in the BSE Sensex are ONGC and NTPC.

In the meantime, NSE Nifty is at 11,828 (down 0.4%). UPL (up 2.4%) is among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,547 to 39,618, registering a gain of 4,071 points (up 10.9%).

ALEMBIC PHARMA Financial Update...

ALEMBIC PHARMA net profit down at Rs 1 billion for the quarter ended March 2019, compared to a loss of Rs 2 billion a year ago. Net Sales declined 9.0% to Rs 9.3 billion during the period as against Rs 10.2 billion in January-March 2018.

For the year ended March 2019, ALEMBIC PHARMA reported 40.8% increase in net profit to Rs 5.9 billion compared to net profit of Rs 4.2 billion during FY18.

Revenue of the company grew 25.7% to Rs 39 billion during FY19.

The current Price to earnings ratio of ALEMBIC PHARMA, based on rolling 12 month earnings, stands at 15.5x.

Stock Market Updates

A Time Correction in the Nifty (Today's Market)

Mar 6, 2021 Momentum Moves

The week belonged to the bulls after bears ended the party in February. March started with gains for the bulls but historically, March has been a bears' month.

Sensex Ends 441 Points Lower; Nifty Settles Below 15,000-Mark (Today's Market)

Mar 5, 2021 Closing

Indian share markets end lower with the Sensex down by 441 points and the Nifty ending down by 143 points.

GRINDWELL NORTON Share Price Down by 5%; BSE CAPITAL GOODS Index Down 1.5% (Today's Market)

Mar 5, 2021 03:30 PM

GRINDWELL NORTON share price is trading down by 5% and its current market price is Rs 950. The BSE CAPITAL GOODS is down by 1.5%. The top gainers in the BSE CAPITAL GOODS Index are V GUARD INDUSTRIES (up 3.3%) and AIA ENGINEERING (up 0.3%). The top losers is GRINDWELL NORTON (down 5.1%).

ADITYA BIRLA CAPITAL Share Price Down by 5%; BSE 500 Index Down 1.1% (Today's Market)

Mar 5, 2021 03:28 PM

ADITYA BIRLA CAPITAL share price is trading down by 5% and its current market price is Rs 131. The BSE 500 is down by 1.1%. The top gainers in the BSE 500 Index are TV18 BROADCAST (up 7.3%) and MOTILAL OSWAL (up 5.9%). The top losers are ADITYA BIRLA CAPITAL (down 5.0%) and APOLLO HOSPITALS (down 5.2%).

HAVELLS INDIA Share Price Down by 5%; BSE CONSUMER DURABLES Index Down 0.7% (Today's Market)

Mar 5, 2021 03:20 PM

HAVELLS INDIA share price is trading down by 5% and its current market price is Rs 1,163. The BSE CONSUMER DURABLES is down by 0.7%. The top gainers in the BSE CONSUMER DURABLES Index are BLUE STAR (up 1.7%) and CROMPTON GREAVES CONSUMER ELEC. (up 1.3%). The top losers is HAVELLS INDIA (down 5.1%).

BALMER LAWRIE Share Price Down by 5%; BSE 500 Index Down 1.1% (Today's Market)

Mar 5, 2021 03:18 PM

BALMER LAWRIE share price is trading down by 5% and its current market price is Rs 148. The BSE 500 is down by 1.1%. The top gainers in the BSE 500 Index are TV18 BROADCAST (up 6.8%) and MOTILAL OSWAL (up 6.1%). The top losers are BALMER LAWRIE (down 5.0%) and APOLLO HOSPITALS (down 5.5%).

View More Indian Share Market News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

S&P BSE SENSEX

50,405.32 -0.87%
Mar 5, 2021 (Close)

FEATURED VIDEOS

A Time Correction in the Nifty

The Best Stocks in a Volatile Market

Gold 65,000 and Silver 84,000 in 2022

How Long Before a Big Stock Market Crash

MARKET STATS

ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

FREE NEWSLETTERS

PREMIUM PRODUCTS

QUICK LINKS

FOLLOW

APP

Equitymaster Agora Research Private Limited (Research Analyst) 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.